Sacituzumab (anti-Trop-2)

Catalog No.A2031 Batch: A203104

Technical Data

CAS No.	1796566-95-4
Isotype	Human IgG1
Source	CHO cells
Storage (From the date of receipt)	Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles.
Purity	99%
Protein concentration	4.05 mg/ml
Endotoxin Level	＜1EU/mg

Biological Activity

Description	Sacituzumab (anti-Trop-2) is a fully humanized IgG1 kappa monoclonal antibody that binds Trop-2.

References	[1] Aditya Bardia,et al. N Engl J Med 2021; 384:1529-1541.

References

[1] Aditya Bardia,et al. N Engl J Med 2021; 384:1529-1541.

Selleck's Sacituzumab (anti-Trop-2) has been cited by 1 publication

TROP2 Expression and Therapeutic Implications in Cutaneous Squamous Cell Carcinoma: Insights From Immunohistochemical and Functional Analysis [ Exp Dermatol, 2024, 33(10):e15196]	PubMed: 39422290

TROP2 Expression and Therapeutic Implications in Cutaneous Squamous Cell Carcinoma: Insights From Immunohistochemical and Functional Analysis [ Exp Dermatol, 2024, 33(10):e15196]

PubMed: 39422290

FOR RESEARCH USE ONLY. NOT FOR USE IN HUMANS.

Specific storage and handling information for each product is indicated on the product datasheet. Most Selleck products are stable under the recommended conditions. Products are sometimes shipped at a temperature that differs from the recommended storage temperature. Short-term storage of many products are stable in the short-term at temperatures that differ from that required for long-term storage.
We ensure that the product is shipped under conditions that will maintain the quality of the reagents. Upon receipt of the product, follow the storage recommendations on the product data sheet.